TUMOR MARKER INDEX (TMI) BASED ON CYFRA21-1 AND CEA IDENTIFIES P-STAGE I NSCLC PATIENTS WITH HIGH RISK OF RECURRENCE AND POOR PROGNOSIS

被引:0
|
作者
Muley, Thomas R. [1 ]
Hoffmann, Hans [1 ]
Dienemann, Hendrik [2 ]
Thomas, Michael [3 ]
Herth, Felix J. F. [4 ]
Meister, Michael [1 ]
机构
[1] Univ Heidelberg, Translat Res Unit, Thoraxklin, D-6900 Heidelberg, Germany
[2] Univ Heidelberg, Dept Surg, Thoraxklin, D-6900 Heidelberg, Germany
[3] Univ Heidelberg, Dept Thorac Oncol, Thoraxklin, D-6900 Heidelberg, Germany
[4] Univ Heidelberg, Dept Pneumol & Resp Med, Thoraxklin, D-6900 Heidelberg, Germany
关键词
Tumor marker index; Stage I; risk prediction; Prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1041 / S1042
页数:2
相关论文
共 21 条
  • [21] Prognostic value of preoperative serum tumor markers, including CEA, Cyfra21-1, SCC, CA19-9, SCC, CA125, TPA, NSE, and SLX, in patients with completely resected pathological stage I non-small cell lung cancer
    Matsuguma, H.
    Suzuki, H.
    Ishikawa, Y.
    Kondo, T.
    Nakahara, R.
    Kamiyama, Y.
    Mori, K.
    Kodama, T.
    Honjo, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)